Physician
Mclaughlin, Suzanne
Mclaughlin, Suzanne was paid $287K by Medicaid between Mar 2018 and Nov 2024, across 19 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoMCLAUGHLIN, SUZANNE
PROVIDENCE, RI 02903
PROVIDENCE, RI 02903
33aNPI1215919782assigned 11/18/2005
33bProvider typeInternal Medicine Physician
28Total paid$287K
24GClaims3,545
24DCodes billed19
24AFirst – last monthMar 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in Rhode Island
Rank by total paid#37 of 386
Median peer was paid$15K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 463 | $21K | |
| 2020 | 529 | $43K | |
| 2021 | 827 | $63K | |
| 2022 | 668 | $64K | |
| 2023 | 714 | $61K | |
| 2024incomplete | 344 | $34K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 907 | 826 | $116K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 1,142 | 1,061 | $100K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4.8% | 463 | 453 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.3% | 264 | 245 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.5% | 115 | 107 | $10K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.5% | 115 | 107 | $10K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.8% | 24 | 24 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.6% | 187 | 173 | $5K |
| 87631 | 1.4% | 19 | 18 | $4K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 12 | 12 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 135 | 116 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 12 | 12 | $2K |
7 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.